These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4697661)

  • 1. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.
    Bailey WC; Taylor SL; Dascomb HE; Greenberg HB; Ziskind MM
    Am Rev Respir Dis; 1973 Apr; 107(4):523-9. PubMed ID: 4697661
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid-associated hepatitis in 114 patients.
    Black M; Mitchell JR; Zimmerman HJ; Ishak KG; Epler GR
    Gastroenterology; 1975 Aug; 69(2):289-302. PubMed ID: 1150039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid hepatitis.
    Maddrey WC; Boitnott JK
    Ann Intern Med; 1973 Jul; 79(1):1-12. PubMed ID: 4721174
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.
    Vanderhoof JA; Ament ME
    J Pediatr; 1976 May; 88(5):867-8. PubMed ID: 1271153
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.
    Byrd RB; Horn BR; Solomon DA; Griggs GA
    JAMA; 1979 Mar; 241(12):1239-41. PubMed ID: 762788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Disturbed hepatic function during isoniazid chemoprophylaxis.
    Levy SA
    Am Rev Respir Dis; 1973 Dec; 108(6):1452-3. PubMed ID: 4751738
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid chemoprophylaxis. Association with detection and incidence of liver toxicity.
    Byrd RB; Horn BR; Griggs GA; Solomon DA
    Arch Intern Med; 1977 Sep; 137(9):1130-3. PubMed ID: 332099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.
    Scharer L; Smith JP
    Ann Intern Med; 1969 Dec; 71(6):1113-20. PubMed ID: 5361410
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.
    Kopanoff DE; Snider DE; Caras GJ
    Am Rev Respir Dis; 1978 Jun; 117(6):991-1001. PubMed ID: 666111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
    Gordin FM; Cohn DL; Matts JP; Chaisson RE; O'Brien RJ; ; ;
    Clin Infect Dis; 2004 Aug; 39(4):561-5. PubMed ID: 15356822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
    Beaudry PH; Brickman HF; Wise MB; MacDougall D
    Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254
    [No Abstract]   [Full Text] [Related]  

  • 13. Close monitoring is essential during isoniazid prophylaxis.
    Atuk NO; Hart AD; Hunt EH
    South Med J; 1977 Feb; 70(2):156-9. PubMed ID: 841390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid hepatotoxicity and acetylation during tuberculosis chemoprophylaxis.
    Myles RK
    Am Rev Respir Dis; 1980 Sep; 122(3):505-6. PubMed ID: 6106445
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of isoniazid on transaminase levels.
    Bailey WC; Weill H; DeRouen TA; Ziskind MM; Jackson HA
    Ann Intern Med; 1974 Aug; 81(2):200-2. PubMed ID: 4843577
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy.
    Mitchell JR; Long MW; Thorgeirsson UP; Jollow DJ
    Chest; 1975 Aug; 68(2):181-90. PubMed ID: 1080096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
    Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
    [No Abstract]   [Full Text] [Related]  

  • 18. Validity of serum glutamic oxalacetic transaminase determinations in isoniazid recipients.
    Bailey WC; Taylor SL; Samuels MS; Dascomb HE; Ziskind M; DeRouen TA
    Am Rev Respir Dis; 1973 Apr; 107(4):670-2. PubMed ID: 4697675
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoniazid toxicity. A prospective study in secondary chemoprophylaxis.
    Byrd CB; Nelson R; Elliott RC
    JAMA; 1972 Jun; 220(11):1471-3. PubMed ID: 5067581
    [No Abstract]   [Full Text] [Related]  

  • 20. The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis.
    Warrington RJ; McPhilips-Feener S; Rutherford WJ
    Clin Allergy; 1982 May; 12(3):217-22. PubMed ID: 7105389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.